MAY - 2023LIFE SCIENCES REVIEW518Strategies for RIM system Selection when Working with Remote teamsJoel Finkle, Associate Director, Regulatory Information Management, BeiGeneCell and Gene therapy Navigating the next frontier in biomanufacturing Narayana Rao, Vice President of Biopharma, Asia Pacific Middle-East Africa, AvantorImproving Minimal Residual Disease Detection Using NGSSteven Henck, PhD, Vice President of R&D, Integrated DNA Technologies16The Tipping Point for Scalable Manufacturing Processes to Pivot Gene TherapiesDr. Linda Randall, AVP, Biologics Development, Manufacturing & Control, Pharmaron2022Proteomics in Health SciencesPhilippe Pinton, VP, Global Head Translational Medicine and Clinical Pharmacology, Ferring Pharmaceuticals23How to efficiently use Dose-Exposure-Response information and modern tools in DMPK and Safetysciences in drug discovery?Dr Riikka Oksala, Director, Head of DMPK & Safety Sciences, R&D, Orion26Accelerating drug development of novel targeted therapies through histology-agnostic oncology clinical trialsHua Gong, M.D., Ph.D., SVP, Global Head of Translational Medicine and Clinical Biomarker, Zai Lab24Medical Affairs Takes Centre StageDr. Sarah Tregenza, PhD, BSc (Hons), APAC Oncology Medical Affairs Director, Pierre Fabre Group27Quality Assurance: Navigating the Escalating Compliance ComplexitiesImelda Rillon, Director, Regional Quality Assurance,Zuellig Pharma08IN MY OPINIONCXO INSIGHTSCXO INSIGHTSCONTENTS
< Page 4 | Page 6 >